1.80MMarket Cap0.00P/E (TTM)
0.000High0.000Low177Volume0.369Open0.370Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)4.85MShares38.00052wk High-0.17P/B1.80MFloat Cap0.30052wk Low--Dividend TTM4.85MShs Float211200.000Historical High--Div YieldTTM0.00%Amplitude0.300Historical Low0.000Avg Price1Lot Size
Panbela Therapeutics Stock Forum
Panbela Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Nant Capital, LLC
Panbela Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Nant Capital, LLC(33.33%),Patrick Soon-Shiong(33.33%)
$Aclarion (ACON.US)$ 0.76%
$SenesTech (SNES.US)$ 7.6%
$Transcode Therapeutics (RNAZ.US)$ 71.11%
$Revelation Biosciences (REVB.US)$ 9.24%
$Panbela Therapeutics (PBLA.US)$ 2.21%
FILL THOSE GAPS
No comment yet